Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
Burn, John
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. [electronic resource] - Lancet (London, England) Dec 2011 - 2081-7 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1474-547X
10.1016/S0140-6736(11)61049-0 doi
Adenoma--prevention & control
Anti-Inflammatory Agents, Non-Steroidal--therapeutic use
Aspirin--therapeutic use
Chemoprevention
Colorectal Neoplasms, Hereditary Nonpolyposis--genetics
Dietary Carbohydrates--therapeutic use
Double-Blind Method
Heterozygote
Humans
Starch--therapeutic use
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. [electronic resource] - Lancet (London, England) Dec 2011 - 2081-7 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1474-547X
10.1016/S0140-6736(11)61049-0 doi
Adenoma--prevention & control
Anti-Inflammatory Agents, Non-Steroidal--therapeutic use
Aspirin--therapeutic use
Chemoprevention
Colorectal Neoplasms, Hereditary Nonpolyposis--genetics
Dietary Carbohydrates--therapeutic use
Double-Blind Method
Heterozygote
Humans
Starch--therapeutic use